| Identifying potential drug targets in the structural proteins of SARS-Cov-2 | Dr Thenmalarchelvi, Associate Professor, Indian Institute of Technology (IIT) Hyderabad | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |
| IND enabling studies and development of CDRI-4655 as anti-hyper-triglyceridemic formulation | Dr Anil Nilkanth Gaikwad, Scientist, CSIR-Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Life Sciences & Biotechnology, Medical Sciences, Pharmaceutical Sciences |
| Development of some mammalian cell based models to screen potent leads that might inhibit viral infection | Prof Partha Roy, Indian Institute of Technology (IIT) Roorkee | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |
| Indian spices and medicinal plants as antiviral against COVID-19 and other related viruses | Prof Vikash Kumar Dubey, Professor, Indian Institute of Technology (IIT), Varanasi | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |
| Identification of global metabolite biomarkers in COVID-19 infected patients for targeted therapy | Dr Sanjeeva Srivastava, Professor, Indian Institute of Technology (IIT), Mumbai | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | COVID-19 Research, Life Sciences & Biotechnology, Pharmaceutical Sciences |
| Development of Monitoring and Evaluation protocol for accelerated MDA (Mass Drug Administration) with IDA (Ivermectin, Diethylcarbamazine and Albendazole) for lymphatic filariasis elimination programme | Dr Jambulingam P, Director, Vector Control Research Centre (ICMR-VCRC), Puducherry | 2019 | Bill & Melinda Gates Foundation (BMGF),
USA | Pharmaceutical Sciences, Life Sciences & Biotechnology, Medical Sciences, Mathematical Sciences |
| Target identification and hit-to-lead optimization of SRI-12742 targeting MDR A baumannii | Dr Sidharth Chopra, Scientist, Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Life Sciences & Biotechnology, Medical Sciences, Pharmaceutical Sciences |
| Determination of biofilm pharmacodynamics of newly formulated, nano-conjugated antibiotics to optimize treatment and dosing of chronic, antibiotic-resistant biofilm infections | Dr Gopal Chandra Kundu, Scientist & Director, National Centre for Cell Science (NCCS), Maharashtra | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Life Sciences & Biotechnology, Medical Sciences, Pharmaceutical Sciences |
| Collaborative Neuro-Engineering Platform for Excellence in Innovation and Translational Research | Prof. Ashish Suri, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi, Prof. Subhashis Banerjee, Professor, Indian Institute of Technology (IIT), Delhi | 2018 | Department of Biotechnology (DBT), Government of Inida | Life Sciences & Biotechnology, Pharmaceutical Sciences |
| Healthcare Technology Innovation Centre (HTIC)-Phase II | Dr. Mohanasankar Sivaprakasam, Associate Professor, Indian Institute of Technology (IIT), Chennai | 2018 | Department of Biotechnology (DBT), Government of Inida | Life Sciences & Biotechnology, Pharmaceutical Sciences |